- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 10 x MYR: MYRISTIC ACID(Non-covalent)(Covalent)
MYR.2: 9 residues within 4Å:- Chain A: Y.107, L.127, Y.154, P.176, M.189, I.191, Y.200, F.232, L.235
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:L.127, A:Y.154, A:Y.154, A:Y.154, A:I.191, A:Y.200, A:F.232, A:F.232, A:L.235
MYR.4: 12 residues within 4Å:- Chain D: G.1, A.2, I.29, Y.31
- Chain G: Q.20
- Chain H: V.4, T.27, T.28, I.29, Y.31
- Ligands: MYR.8, MYR.20
4 PLIP interactions:2 interactions with chain H, 2 interactions with chain D- Hydrophobic interactions: H:I.29, D:I.29, D:Y.31
- Hydrogen bonds: H:T.27
MYR.6: 9 residues within 4Å:- Chain E: Y.107, L.127, Y.154, P.176, M.189, I.191, Y.200, F.232, L.235
9 PLIP interactions:9 interactions with chain E- Hydrophobic interactions: E:L.127, E:Y.154, E:Y.154, E:Y.154, E:I.191, E:Y.200, E:F.232, E:F.232, E:L.235
MYR.8: 12 residues within 4Å:- Chain H: G.1, A.2, I.29, Y.31
- Chain K: Q.20
- Chain L: V.4, T.27, T.28, I.29, Y.31
- Ligands: MYR.4, MYR.12
4 PLIP interactions:2 interactions with chain L, 2 interactions with chain H- Hydrophobic interactions: L:I.29, H:I.29, H:Y.31
- Hydrogen bonds: L:T.27
MYR.10: 9 residues within 4Å:- Chain I: Y.107, L.127, Y.154, P.176, M.189, I.191, Y.200, F.232, L.235
9 PLIP interactions:9 interactions with chain I- Hydrophobic interactions: I:L.127, I:Y.154, I:Y.154, I:Y.154, I:I.191, I:Y.200, I:F.232, I:F.232, I:L.235
MYR.12: 12 residues within 4Å:- Chain L: G.1, A.2, I.29, Y.31
- Chain O: Q.20
- Chain P: V.4, T.27, T.28, I.29, Y.31
- Ligands: MYR.8, MYR.16
3 PLIP interactions:2 interactions with chain L, 1 interactions with chain P- Hydrophobic interactions: L:I.29, L:Y.31, P:I.29
MYR.14: 9 residues within 4Å:- Chain M: Y.107, L.127, Y.154, P.176, M.189, I.191, Y.200, F.232, L.235
9 PLIP interactions:9 interactions with chain M- Hydrophobic interactions: M:L.127, M:Y.154, M:Y.154, M:Y.154, M:I.191, M:Y.200, M:F.232, M:F.232, M:L.235
MYR.16: 12 residues within 4Å:- Chain P: G.1, A.2, I.29, Y.31
- Chain S: Q.20
- Chain T: V.4, T.27, T.28, I.29, Y.31
- Ligands: MYR.12, MYR.20
3 PLIP interactions:2 interactions with chain P, 1 interactions with chain T- Hydrophobic interactions: P:I.29, P:Y.31, T:I.29
MYR.18: 9 residues within 4Å:- Chain Q: Y.107, L.127, Y.154, P.176, M.189, I.191, Y.200, F.232, L.235
9 PLIP interactions:9 interactions with chain Q- Hydrophobic interactions: Q:L.127, Q:Y.154, Q:Y.154, Q:Y.154, Q:I.191, Q:Y.200, Q:F.232, Q:F.232, Q:L.235
MYR.20: 12 residues within 4Å:- Chain C: Q.20
- Chain D: V.4, T.27, T.28, I.29, Y.31
- Chain T: G.1, A.2, I.29, Y.31
- Ligands: MYR.4, MYR.16
4 PLIP interactions:2 interactions with chain T, 2 interactions with chain D- Hydrophobic interactions: T:I.29, T:Y.31, D:I.29
- Hydrogen bonds: D:T.27
- 5 x 5GP: GUANOSINE-5'-MONOPHOSPHATE(Non-covalent)
5GP.3: 2 residues within 4Å:- Chain B: W.38
- Chain D: K.57
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain D- pi-Stacking: B:W.38, B:W.38, B:W.38, B:W.38
- Hydrogen bonds: D:K.57
- Salt bridges: D:K.57
5GP.7: 2 residues within 4Å:- Chain F: W.38
- Chain H: K.57
6 PLIP interactions:2 interactions with chain H, 4 interactions with chain F- Hydrogen bonds: H:K.57
- Salt bridges: H:K.57
- pi-Stacking: F:W.38, F:W.38, F:W.38, F:W.38
5GP.11: 2 residues within 4Å:- Chain J: W.38
- Chain L: K.57
6 PLIP interactions:2 interactions with chain L, 4 interactions with chain J- Hydrogen bonds: L:K.57
- Salt bridges: L:K.57
- pi-Stacking: J:W.38, J:W.38, J:W.38, J:W.38
5GP.15: 2 residues within 4Å:- Chain N: W.38
- Chain P: K.57
6 PLIP interactions:4 interactions with chain N, 2 interactions with chain P- pi-Stacking: N:W.38, N:W.38, N:W.38, N:W.38
- Hydrogen bonds: P:K.57
- Salt bridges: P:K.57
5GP.19: 2 residues within 4Å:- Chain R: W.38
- Chain T: K.57
6 PLIP interactions:4 interactions with chain R, 2 interactions with chain T- pi-Stacking: R:W.38, R:W.38, R:W.38, R:W.38
- Hydrogen bonds: T:K.57
- Salt bridges: T:K.57
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, C. et al., The crystal structure of coxsackievirus a21 and its interaction with icam-1. Structure (2005)
- Release Date
- 2005-08-02
- Peptides
- Human COXSACKIEVIRUS A21: AEIMQ
Human COXSACKIEVIRUS A21: BFJNR
Human coxsackievirus A21: CGKOS
Human coxsackievirus A21: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1B
2F
2J
2N
2R
2C
3G
3K
3O
3S
3D
4H
4L
4P
4T
4
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x CA: CALCIUM ION(Non-covalent)
- 10 x MYR: MYRISTIC ACID(Non-covalent)(Covalent)
- 5 x 5GP: GUANOSINE-5'-MONOPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xiao, C. et al., The crystal structure of coxsackievirus a21 and its interaction with icam-1. Structure (2005)
- Release Date
- 2005-08-02
- Peptides
- Human COXSACKIEVIRUS A21: AEIMQ
Human COXSACKIEVIRUS A21: BFJNR
Human coxsackievirus A21: CGKOS
Human coxsackievirus A21: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1B
2F
2J
2N
2R
2C
3G
3K
3O
3S
3D
4H
4L
4P
4T
4